Encompass Health Corporation Common Stock (EHC)
Stock · NYSE · Health Care
$127.87as of 10/16/2026
Price chart
Active signals
EHC Signal Track Record
How signals performed across all stocks →What EHC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 35 | +4.4% | 71% | September 18, 2026 |
| Bollinger Band Breakout | 22 | +2.3% | 68% | September 16, 2026 |
| Bollinger Band Breakdown | 19 | -0.5% | 47% | October 1, 2026 |
| 200-Day Moving Average TouchActive now | 13 | +3.3% | 62% | July 6, 2026 |
| Any 20-session window (baseline) | +2.1% | 63% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About EHC
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitativ…
- Sector
- Health Care
- Industry
- Hospital/Nursing Management
- Employees
- 29,699
- Website
- www.encompasshealth.com/
Fundamentals
- 1-day range
- $118.39$120.89
- Market cap
- $12.38B
- P/E (trailing)
- 20.06
- P/E (forward)
- 17.94
- EPS (trailing)
- $6.14
- Dividend yield
- 0.91%
- Beta
- 0.86
- Avg. volume
- 918.5K
- Ex-dividend date
- October 1, 2026
- Dividend pay date
- October 15, 2026
How Encompass Health Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 26, 2026 · via SEC EDGAR / Finnhub
Forecasts
12 analyst ratings
Encompass Health Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- EHCEncompass Health Corporation Common Stock$127.87▲ 0.08%Market cap $12.38BP/E 20.06$92.77$127.99
- ENSGThe Ensign Group Inc. Common Stock$176.63▼ 0.83%Market cap $10.59BP/E 27.51$141.58$218
- UHSUniversal Health Services Inc. Common Stock$185.1▼ 1.21%Market cap $10.27BP/E 7.27$140.08$246.33
- PACSPACS Group Inc. Common Stock$46.91▼ 1.76%Market cap $7.39BP/E 28.09$10.31$49.49
- THCTenet Healthcare Corporation Common Stock$267.25▼ 2.86%Market cap $20.66BP/E 9.77$157.58$283.05
- BKDBrookdale Senior Living Inc. Common Stock$10.09▲ 0.00%Market cap $3.43BP/E —$8.02$17.09
- NHCNational HealthCare Corporation Common Stock$242.82▼ 1.10%Market cap $3.43BP/E 26.97$117.22$239.29
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| EHC Encompass Health Corporation Common Stock | $12.38B | 20.06 | $127.87 | ▲ 0.08% | $92.77$127.99 |
| ENSG The Ensign Group Inc. Common Stock | $10.59B | 27.51 | $176.63 | ▼ 0.83% | $141.58$218 |
| UHS Universal Health Services Inc. Common Stock | $10.27B | 7.27 | $185.1 | ▼ 1.21% | $140.08$246.33 |
| PACS PACS Group Inc. Common Stock | $7.39B | 28.09 | $46.91 | ▼ 1.76% | $10.31$49.49 |
| THC Tenet Healthcare Corporation Common Stock | $20.66B | 9.77 | $267.25 | ▼ 2.86% | $157.58$283.05 |
| BKD Brookdale Senior Living Inc. Common Stock | $3.43B | — | $10.09 | ▲ 0.00% | $8.02$17.09 |
| NHC National HealthCare Corporation Common Stock | $3.43B | 26.97 | $242.82 | ▼ 1.10% | $117.22$239.29 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 1 Momentum Stock to Research Further and 2 We Turn DownYahoo · 10/2/2026
- Encompass Health announces date of 2026 third-quarter earnings callYahoo · 10/1/2026
- If You Invested $100 In Encompass Health Stock 15 Years Ago, You Would Have This Much TodayBenzinga · 9/30/2026
- Will Encompass Health’s Small-Format Expansion Strategy Reshape EHC’s Capacity-Led Growth Narrative?Yahoo · 9/28/2026
- Encompass Health (EHC) Could Be 20% Undervalued As Rehab Expansion Builds OutYahoo · 9/28/2026
- Encompass Health Adds New Capacity With First Small-Format HospitalYahoo · 9/25/2026
- 2 Cash-Producing Stocks with Promising Prospects and 1 Facing HeadwindsYahoo · 9/25/2026
- Encompass Health expands in Montgomery County, Texas, with first small-format hospital, replacement hospitalYahoo · 9/24/2026
Insider Activity
Insider Actions →- John Patrick Darby · August 31, 2026 · Option Exercise4.9K @ $35.06
- John Patrick Darby · August 31, 2026 · Sale4.9K @ $121.09
- Andrew L. Price · August 31, 2026 · Sale5.2K @ $120.93
- John Patrick Darby · August 10, 2026 · Sale8.9K @ $125.95
- Mark J. Tarr · August 10, 2026 · Sale1.6K @ $126.06
- Mark J. Tarr · August 10, 2026 · Sale171.6K @ $125.46
- Douglas E. Coltharp · August 10, 2026 · Sale18.9K @ $125.38
- Edward M. Christie III · July 16, 2026 · Grant248 @ $112.43
- Christopher R. Reidy · July 16, 2026 · Grant319 @ $112.4
- Cain A. Hayes · July 15, 2026 · Grant4
- Kevin J. O'Connor · July 15, 2026 · Grant19
- Terrance Williams · July 15, 2026 · Grant29
- Edward M. Christie III · July 15, 2026 · Grant11
- Nancy M. Schlichting · July 15, 2026 · Grant40
- Christopher R. Reidy · July 15, 2026 · Grant21
Institutional Ownership
March 31, 2026
- Total shares held
- 89.13M
- Total value held
- $7.58B
- Institutional holders
- 567
- Unknown10.77M
- Unknown4.60M
- Unknown4.47M
- Unknown3.85M
- Unknown3.39M
- Unknown3.23M
- Unknown3.14M
- Unknown2.62M
- Unknown2.23M
- Unknown2.22M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Encompass Health Sets Q3 2026 Earnings Call Date
Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.
Encompass Health Sets Q3 2026 Earnings Call Date. Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.